Thierry Bernard

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Lexington, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Simone, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thierry Bernard

Form 4 holding Director

NEOGEN CORP

Security class
Common Stock (Right to Buy)
Shares / value
50,814
Estimated value
$237,629
Report date
23 Oct 2025
Price
$13.81
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NEOGEN CORP

Security class
Restricted Stock Units
Shares / value
5,620
Estimated value
$81,153
Report date
01 Nov 2024
Price
$14.44
Ownership
Direct
Form 4 holding Director

T2 Biosystems, Inc.

Security class
Common Stock
Shares / value
7,322
Estimated value
$1,153
Report date
15 Sep 2023
Price
$0.1575
Ownership
Direct
Form 4 holding Director

T2 Biosystems, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
15 Sep 2023
Price
$0.1575
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thierry Bernard

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .